Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway.

Jiang L, He D, Yang D, Chen Z, Pan Q, Mao A, Cai Y, Li X, Xing H, Shi M, Chen Y, Bruce IC, Wang T, Jin L, Qi X, Hua D, Jin J, Ma X.

FEBS Lett. 2014 May 29;588(11):2009-15. doi: 10.1016/j.febslet.2014.04.024. Epub 2014 Apr 29.

2.

miR-145 regulates chemoresistance in hepatocellular carcinoma via epithelial mesenchymal transition.

Ju BL, Chen YB, Zhang WY, Yu CH, Zhu DQ, Jin J.

Cell Mol Biol (Noisy-le-grand). 2015 May 8;61(3):12-6.

PMID:
26068913
3.

Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.

He DX, Gu XT, Li YR, Jiang L, Jin J, Ma X.

FEBS J. 2014 Oct;281(20):4718-30. doi: 10.1111/febs.13012. Epub 2014 Sep 30.

4.

The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.

Zhu Y, Wu J, Li S, Ma R, Cao H, Ji M, Jing C, Tang J.

Cell Physiol Biochem. 2013;32(5):1225-37. doi: 10.1159/000354521. Epub 2013 Nov 14.

5.

MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition.

Jin Z, Guan L, Song Y, Xiang GM, Chen SX, Gao B.

Eur Rev Med Pharmacol Sci. 2016;20(6):1080-6.

6.

miRNA expression patterns in chemoresistant breast cancer tissues.

Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.

Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.

PMID:
25451164
7.

MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.

Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ, Zhao JH, Tang JH.

Arch Med Res. 2012 Oct;43(7):514-21. doi: 10.1016/j.arcmed.2012.09.007. Epub 2012 Oct 16.

PMID:
23085450
8.

The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).

Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L.

J Biol Chem. 2013 Apr 19;288(16):10973-85. doi: 10.1074/jbc.M112.434340. Epub 2013 Feb 22.

9.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
10.

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T.

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

11.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
12.

Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.

Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S.

Am J Pathol. 2012 Jun;180(6):2490-503. doi: 10.1016/j.ajpath.2012.02.024. Epub 2012 Apr 19.

13.

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.

Liao H, Bai Y, Qiu S, Zheng L, Huang L, Liu T, Wang X, Liu Y, Xu N, Yan X, Guo H.

Oncotarget. 2015 Apr 20;6(11):8914-28.

14.

The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.

Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2321-32. doi: 10.1016/j.biocel.2012.08.006. Epub 2012 Aug 10.

PMID:
22903020
15.

MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer.

Wu ZH, Tao ZH, Zhang J, Li T, Ni C, Xie J, Zhang JF, Hu XC.

Tumour Biol. 2016 Jun;37(6):7245-54. doi: 10.1007/s13277-015-4604-7. Epub 2015 Dec 14.

PMID:
26666820
16.

miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells.

Hu SH, Wang CH, Huang ZJ, Liu F, Xu CW, Li XL, Chen GQ.

Eur Rev Med Pharmacol Sci. 2016 Dec;20(23):5002-5008.

17.

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.

Ward A, Balwierz A, Zhang JD, Küblbeck M, Pawitan Y, Hielscher T, Wiemann S, Sahin Ö.

Oncogene. 2013 Feb 28;32(9):1173-82. doi: 10.1038/onc.2012.128. Epub 2012 Apr 16.

PMID:
22508479
18.

Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.

Lv J, Fu Z, Shi M, Xia K, Ji C, Xu P, Lv M, Pan B, Dai L, Xie H.

Biomed Pharmacother. 2015 Feb;69:162-9. doi: 10.1016/j.biopha.2014.11.028. Epub 2014 Nov 25.

PMID:
25661353
19.

MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.

Chen D, Huang J, Zhang K, Pan B, Chen J, De W, Wang R, Chen L.

Eur J Cancer. 2014 Nov;50(17):3050-67. doi: 10.1016/j.ejca.2014.09.008. Epub 2014 Oct 10.

PMID:
25310895
20.

MiR-888 regulates side population properties and cancer metastasis in breast cancer cells.

Huang S, Chen L.

Biochem Biophys Res Commun. 2014 Aug 8;450(4):1234-40. doi: 10.1016/j.bbrc.2014.05.022. Epub 2014 May 15.

PMID:
24845571

Supplemental Content

Support Center